Crewe Advisors’s Zimmer Biomet ZBH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $10.9K | Hold |
120
| – | – | ﹤0.01% | 627 |
|
|
2025
Q4 | $10.8K | Hold |
120
| – | – | ﹤0.01% | 607 |
|
|
2025
Q3 | $11.8K | Hold |
120
| – | – | ﹤0.01% | 596 |
|
|
2025
Q2 | $10.9K | Hold |
120
| – | – | ﹤0.01% | 447 |
|
|
2025
Q1 | $13.6K | Hold |
120
| – | – | ﹤0.01% | 395 |
|
|
2024
Q4 | $12.7K | Sell |
120
-34
| -22% | -$3.65K | ﹤0.01% | 406 |
|
|
2024
Q3 | $16.6K | Sell |
154
-80
| -34% | -$8.73K | ﹤0.01% | 426 |
|
|
2024
Q2 | $25.4K | Hold |
234
| – | – | ﹤0.01% | 509 |
|
|
2024
Q1 | $30.9K | Buy |
+234
| New | +$29.2K | ﹤0.01% | 432 |
|
|
2023
Q4 | – | Sell |
-200
| Closed | -$22.4K | – | 714 |
|
|
2023
Q3 | $22.4K | Hold |
200
| – | – | ﹤0.01% | 192 |
|
|
2023
Q2 | $29.1K | Hold |
200
| – | – | ﹤0.01% | 322 |
|
|
2023
Q1 | $25.8K | Sell |
200
-24
| -11% | -$3.01K | ﹤0.01% | 383 |
|
|
2022
Q4 | $28.6K | Sell |
224
-86
| -28% | -$9.98K | ﹤0.01% | 369 |
|
|
2022
Q3 | $32K | Buy |
310
+35
| +13% | +$3.84K | 0.01% | 383 |
|
|
2022
Q2 | $29K | Buy |
275
+75
| +38% | +$8.9K | 0.01% | 362 |
|
|
2022
Q1 | $26K | Buy |
200
+76
| +61% | +$9.16K | 0.01% | 282 |
|
|
2021
Q4 | $15K | Hold |
124
| – | – | ﹤0.01% | 295 |
|
|
2021
Q3 | $18K | Sell |
124
-80
| -39% | -$11.8K | ﹤0.01% | 222 |
|
|
2021
Q2 | $32K | Hold |
204
| – | – | 0.01% | 184 |
|
|
2021
Q1 | $32K | Hold |
204
| – | – | 0.01% | 183 |
|
|
2020
Q4 | $31K | Hold |
204
| – | – | 0.01% | 172 |
|
|
2020
Q3 | $27K | Buy |
204
+80
| +65% | +$10.5K | 0.01% | 168 |
|
|
2020
Q2 | $14K | Hold |
124
| – | – | 0.01% | 152 |
|
|
2020
Q1 | $12K | Sell |
124
-23
| -16% | -$3.02K | 0.01% | 140 |
|
|
2019
Q4 | $21K | Buy |
147
+23
| +19% | +$3.17K | 0.01% | 152 |
|
|
2019
Q3 | $16K | Hold |
124
| – | – | 0.01% | 169 |
|
|
2019
Q2 | $14K | Hold |
124
| – | – | ﹤0.01% | 200 |
|
|
2019
Q1 | $15K | Hold |
124
| – | – | ﹤0.01% | 170 |
|
|
2018
Q4 | $12K | Hold |
124
| – | – | ﹤0.01% | 178 |
|
|
2018
Q3 | $16K | Sell |
124
-123
| -50% | -$14.6K | 0.01% | 182 |
|
|
2018
Q2 | $26K | Buy |
247
+123
| +99% | +$13.4K | 0.02% | 161 |
|
|
2018
Q1 | $13K | Hold |
124
| – | – | 0.01% | 211 |
|
|
2017
Q4 | $14K | Buy |
+124
| New | +$14K | 0.01% | 207 |
|
Other funds holding ZBH
VCM
VPM
Crewe Advisors's ZBH Position: Q1 2026 in Review
Crewe Advisors held its Zimmer Biomet (ZBH) position steady in Q1 2026 at 120 shares worth $10.9K. The position accounts for ﹤0.01% of the portfolio, ranked #627.
Crewe Advisors first reported a position in ZBH in Q4 2017 and has held it in 33 quarters since. The position peaked at $32K in Q3 2022. 912 funds tracked by Wall St. Rank hold ZBH as of Q1 2026.
- Crewe Advisors held 120 shares of Zimmer Biomet worth $10.9K as of Q1 2026.
- Crewe Advisors left its Zimmer Biomet share count unchanged in Q1 2026.
- Zimmer Biomet made up ﹤0.01% of Crewe Advisors's portfolio in Q1 2026, its #627 holding.
- Crewe Advisors first reported a position in Zimmer Biomet in Q4 2017 and has held it in 33 quarters since.
- Crewe Advisors's Zimmer Biomet position peaked at $32K in Q3 2022.
- 912 funds tracked by Wall St. Rank held Zimmer Biomet as of Q1 2026.
Based on Crewe Advisors's 13F filing for Q1 2026, filed 7 May 2026.